$ONCY News Article - Oncolytics Biotech(R) Announces Publication of Positive REO 024 Study Results for Pelareorep in Combination with Keytruda(R) in Patients with Advanced Pancreatic Adenocarcinoma
https://marketwirenews.com/news-releases/onco...98438.html